New players to enter EU’s COVID vaccines playground
The EU’s drugs agency EMA has started evaluating an application for conditional marketing authorisation for US biotech firm Novavax’s COVID-19 vaccine, Nuvaxovid. If granted, this will be the fifth vaccine authorised in the European Union. The assessment will proceed under an accelerated timeline, and an opinion on the marketing authorisation could be issued within weeks if the data submitted […]
